LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

Home・Lista de Ações・Microbot Medical Inc

Microbot Medical Inc

Fechado

2.14 2.39

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

2.14

Máximo

2.14

Indicadores-chave
By Trading Economics
Rendimento	-77K -3.6M
Funcionários	20
EBITDA	-79K -3.6M

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	+264.08% upside

Dividendos
By Dow Jones
Próximos Ganhos	23 de mar. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	5.4M 146M
Abertura anterior	-0.25
Fecho anterior	2.14

Pontuação Técnica

By Trading Central

Confiança

Neutral Evidence

2.52 / 2.57 Suporte e Resistência

Microbot Medical Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

22 de fev. de 2026, 23:55 UTC

Conversa de Mercado

Gold and Silver Rise Amid Renewed Trade Tensions -- Market Talk

22 de fev. de 2026, 23:53 UTC

Conversa de Mercado

Japan Activity Data Set to Show Strength, Backed by Fiscal Spending -- Market Talk

22 de fev. de 2026, 23:53 UTC

Conversa de Mercado

Key China Rates Likely to Be Held Steady for Now -- Market Talk

22 de fev. de 2026, 23:51 UTC

Conversa de Mercado

Bank of Korea Set to Hold Fire as Inflation Steadies, Risks Linger -- Market Talk

22 de fev. de 2026, 23:35 UTC

Conversa de Mercado

Oil Falls Amid Prospect That U.S. Strike on Iran Might Be Limited -- Market Talk

22 de fev. de 2026, 23:21 UTC

Ganhos

Nickel Industries 2025 Adjusted Ebitda US$283.0 Million

22 de fev. de 2026, 23:20 UTC

Ganhos

Nickel Industries 2025 Operating Profit US$126.4 Million

22 de fev. de 2026, 23:19 UTC

Ganhos

Nickel Industries 2025 Revenue US$1.65 Billion, Down 5.5% On-Year

22 de fev. de 2026, 23:19 UTC

Ganhos

Correct: Nickel Industries 2025 Net Loss US$57.1 Million, Down 66% On-Year

22 de fev. de 2026, 23:18 UTC

Ganhos

Nickel Industries Won't Pay a Final Dividend

22 de fev. de 2026, 23:16 UTC

Ganhos

Nickel Industries 2025 Net Loss A$57.1 Million, Down 66% On-Year

22 de fev. de 2026, 21:35 UTC

Ganhos

Ampol Expects to Start Commissioning of Ultra Low Sulfur Fuels Project in 2Q

22 de fev. de 2026, 21:34 UTC

Ganhos

Ampol Says F&I Australia, International Have Begun 2026 Strongly

22 de fev. de 2026, 21:34 UTC

Ganhos

Ampol Expects Stage 1 of Fuel Security Services Payment Review Finalized in 1Q

22 de fev. de 2026, 21:33 UTC

Ganhos

Ampol Says Lytton Refiner Margin Was US$8.13/bbl in January

22 de fev. de 2026, 21:33 UTC

Ganhos

Ampol Recognizes A$89.9 Million Impairment in Carrying Value of Investment in Seaoil

22 de fev. de 2026, 21:28 UTC

Ganhos

Ampol Final Dividend A$0.60/Share

22 de fev. de 2026, 21:28 UTC

Ganhos

Ampol FY Revenue A$31.37 Billion, Down 10%

22 de fev. de 2026, 21:28 UTC

Ganhos

Ampol FY Replacement-Cost Net Profit A$429.2 Million, Up 83%

22 de fev. de 2026, 21:28 UTC

Ganhos

Ampol FY Historical-Cost Net Profit A$82.4 Million, Down 33%

21 de fev. de 2026, 14:31 UTC

Aquisições, Fusões, Aquisições de Empresas

Bridgewater Associates' 4Q Buying and Selling -- Barrons.com

21 de fev. de 2026, 05:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

20 de fev. de 2026, 23:12 UTC

Aquisições, Fusões, Aquisições de Empresas

FERC Authorizes TXNM Energy Acquisition by Blackstone Infrastructure

20 de fev. de 2026, 22:12 UTC

Ganhos

Equinox Gold: Announces Filing of 2025 Audited Fincl Statements

20 de fev. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

20 de fev. de 2026, 21:50 UTC

Conversa de Mercado

Auto & Transport Roundup: Market Talk

20 de fev. de 2026, 21:23 UTC

Ganhos

These Stocks Are Today's Movers: Grail, Corning, Comfort Systems USA, Opendoor, Akamai, Chemours, and More -- Barrons.com

20 de fev. de 2026, 21:20 UTC

Conversa de Mercado

Century Aluminum Backs Trump's Tariffs After SCOTUS Ruling -- Market Talk

20 de fev. de 2026, 21:01 UTC

Aquisições, Fusões, Aquisições de Empresas

Want to Win the Warner Bros. Discovery Takeover Battle? 'Walk Away Now.' -- Barrons.com

20 de fev. de 2026, 20:38 UTC

Conversa de Mercado

U.S. Natural Gas Gains Ahead of Chilly Weekend -- Market Talk

Comparação entre Pares

Variação de preço

Microbot Medical Inc Previsão

Preço-alvo

By TipRanks

264.08% parte superior

Previsão para 12 meses

Média 7.5 USD 264.08%

Máximo 12 USD

Mínimo 5 USD

Com base em 3 analistas de Wall Street que oferecem metas de preço de 12 meses para Microbot Medical Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

3 ratings

Comprar

Manter

Vender

Com base em 3 analistas que deram avaliações de ações para Microbot Medical Inc - Dist nos últimos 3 meses.

Pontuação Técnica

By Trading Central

2.52 / 2.57Suporte e Resistência

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.